This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-148358-q30zlgwy | does full financial integration exist in european government bond markets? |
| cord-258885-ev2pvr3s | What opportunities could the COVID-19 outbreak offer for sustainability transitions research on electricity and mobility? |
| cord-022903-08ugoxns | -comparison with elisa and direct immunofluorescence of nasal epithelial- cells Metal- mediated oxidative DNA damage induced by methylene blue Importance of colostrum for raising newborn calves Pathogenesis of neurological signs associated with bovine enteric coccidiosis-a prospective- study and review Enzymatic properties of cellobiose 2-epimerase from Ruminococcus albus and the synthesis of rare oligosaccharides by the enzyme Effects of nitrilotriacetic acid on apparent absorption and duodenal flow of manganese, iron, zinc and copper in sheep Alternative approaches to control-Quo vadit? |
| cord-025724-ea09nbkh | Brussels- based advocacy group aimed to provide single voice for scientists in the EU- but is losing members Key Findings from the Horizon EU- Forschungspolitik- von der Industrieförderung zu einer pan- europäischen Wissenschaftspolitik? |
| cord-025724-ea09nbkh | The European Science Foundation; Death or Mid- Life Crisis? |
| cord-035132-6hih3qoy | The definition of the London Communiqué responds to a basic question for citizens and policy makers alike,"what kind of higher education system do we wish to develop? |
| cord-306184-wfvc35l5 | Global access to quality- assured medical products: the Oxford statement and call to action A link between poor quality antimalarials and malaria drug resistance? |
| cord-308821-j4vylbhy | How prepared is Europe for pandemic influenza? |
| cord-280733-d44se0v3 | What is the evidence for physical therapy poststroke? |
| cord-297286-bo6pr34s | How can we achieve all, or most of these aims if it is not possible to meet in person? |
| cord-297286-bo6pr34s | The Independent Covid-19 and the digestive system Neurologic manifestations of hospitalized patients with coronavirus disease Cardiovascular complications in COVID-19 Adapting to a new normal? |
| cord-264770-93viq4ak | Gaps Between Countries and Global Perspectives Toward a European definition for a drug shortage: a qualitative study Challenges to orphan drugs access in Eastern Europe: the case of Bulgaria How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? |
| cord-264770-93viq4ak | Word Health Organization Regional Office for Europe Causes of drug shortages in the legal pharmaceutical framework Drug Shortages: Root Causes and Potential Solutions Drug shortages in European countries: a trade- off between market attractiveness and cost containment? |
| cord-289555-1z4vbldd | A review of the global conservation status of bats Emerging diseases in Chiroptera: why bats? |
| cord-289555-1z4vbldd | Host and viral ecology determine bat rabies seasonality and maintenance Seasonal activity patterns of seven vespertilionid bat species in Polish lowlands Hibernation: the immune system at rest? |
| cord-275209-j0za3g3p | Pseudorabies virus infections in European wild boar- a potential danger for domestic pigs? |
| cord-275209-j0za3g3p | und Ansteckungsquelle für Hausschweine? |
| cord-017024-7amhia06 | The rabbit: a diurnal or nocturnal animal? |
| cord-017024-7amhia06 | what does the rabbit see and how do they affect behaviour? |
| cord-304056-2bo0s0hz | Finally, the next important phase for SADC is the implementation of the agreed- upon standards, recommendations, and plans( e.g., How will the proposed actions to"strengthen national DRA capacity to implement harmonized SADC guidelines"be managed?). |
| cord-293542-o0zspgrk | Global trends in emerging infectious diseases Climate change and infectious disease: a dangerous liaison? |
| cord-293542-o0zspgrk | How prepared is Europe for pandemic influenza? |
| cord-304887-7ly692to | Do future- oriented innovation strategies suffer? |
| cord-304887-7ly692to | Steel industry co- products-worldsteel position paper Energy prices and emissions trading: Windfall profits from grandfathering? |
| cord-304887-7ly692to | Where are the industrial technologies in energy- economy models? |
| cord-308284-r546ypur | The question then arose: How many lives would have been saved if effective medical countermeasures had been made available sooner? |
| cord-302127-1abupl36 | What's Changed? |
| cord-347182-oj3v1x99 | COVID-19, i casi in Italia Coronavirus testing: how are the hardest- hit countries responding? |
| cord-350164-dzma5ye7 | How are food environments and health status across the WHO European Region transforming during the pandemic, and how will they continue to change after response measures have been lifted and in the months and years to come? |
| cord-350164-dzma5ye7 | João J. title: Disrupted food systems in the WHO European region – a threat or opportunity for healthy and sustainable food and nutrition? |
| cord-031090-dd8z7stt | However, what happens if the price gouging is genuinely unilateral and not collusive, due to an abnormal level of demand, in terms of both the number of consumers who desire the item and the sense of urgency that increases that desire? |
| cord-031090-dd8z7stt | What happens if there is not only one dominant company in the market that sets excessive prices on goods and services in high demand? |
| cord-292093-6pp9l4j2 | Answering the skeptics: Yes, standard volatility models do provide accurate forecasts Modeling and forecasting realized volatility Stock markets'reaction to COVID-19: cases or fatalities? |
| cord-292093-6pp9l4j2 | The model confidence set A General Approach to Testing Volatility Models in Time Series Which sentiment index is more informative to forecast stock market volatility? |
| cord-319066-jdvvegp9 | If your only criterion for suspected COVID-19 is close contact with a confirmed COVID-19 case and the child is otherwise asymptomatic and well, do you test/ will you test the child in the ED/ PED for SARS- CoV-2? |
| cord-319066-jdvvegp9 | What is the patient flow for a suspected COVID-19 in your ED/ PED after pre- triage? |
| cord-035030-ig4nwtmi | Clinical and EEG mapping study Effects of acetyl- L- carnitine on Cardiac Dysautonomia in Rett Syndrome: Prevention of Sudden Death? |
| cord-035030-ig4nwtmi | How can we as patient representatives get the fruits of the ERNs into the national health system? |
| cord-035030-ig4nwtmi | What will be the role of technology in care delivery? |
| cord-035030-ig4nwtmi | Which scenarios are most likely to happen? |
| cord-035030-ig4nwtmi | Which scenarios are most preferred by the RD community? 2. |
| cord-035030-ig4nwtmi | Will there be easier access to expert multidisciplinary teams? |
| cord-290351-5sct52t4 | can we learn from our past for the future? |
| cord-290351-5sct52t4 | key: cord-290351- 5sct52t4 authors: Kujundžić Tiljak, Mirjana; Reiner, Željko; Klarica, Marijan title: Is there a better future of healthy aging? |
| cord-016285-cwhmm3f6 | The ultimate answer? |
| cord-016285-cwhmm3f6 | The ultimate challenge? |
| cord-016285-cwhmm3f6 | key: cord-016285-cwhmm3f6 authors: nan title: Challenges to the European Exception: What Can S&T Do? date: 2006 journal: |
| cord-024349-f8hm9v9g | Can the EU take over the proclaimed stewardship responsibility? |
| cord-024349-f8hm9v9g | Squaring the Circle? |
| cord-024349-f8hm9v9g | What can law contribute to the building of a national society? |
| cord-024349-f8hm9v9g | What, then, does rethinkingthinking the unthinkableimply? |
| cord-024349-f8hm9v9g | Who is the addressee? |
| cord-029160-z2sxr3dx | A fragile and divided European Union meets Covid-19: Further disintegration or'Hamiltonian moment Crisis in the European Monetary Union: A core- periphery perspective Bringing it all back home? |
| cord-029160-z2sxr3dx | If so, why? |
| cord-029160-z2sxr3dx | The coming coronavirus crisis: What can we learn? |
| cord-029160-z2sxr3dx | Why has China's vertical specialization declined? |
| cord-029160-z2sxr3dx | global and regional value chains Is there an investment gap in advanced economies? |
| cord-029160-z2sxr3dx | the only available options or are there alternatives? |
| cord-354884-q8634dyc | Can we be certain about future land use change in Europe? |
| cord-354884-q8634dyc | Does the intuitive logics method-and its recent enhancements-produce"effective"scenarios? |
| cord-354884-q8634dyc | The origins and evolution of scenario techniques in long range business planning Future European agricultural landscapes- what can we learn from existing quantitative land use scenario studies? |
| cord-322078-cli7mpev | And to relaunch a system with such inertia after weeks and months of deprivation, if many companies no longer exist, will take tremendous effort? |
| cord-322078-cli7mpev | But how will things develop if the situation is not resolved in a few weeks'time? |
| cord-322078-cli7mpev | For example, how is it that in the UK, home to some of the finest educational and research institutions and to a good proportion of the richest people in the world, only approximately 4000 ICU beds exist-for a population of approximately 66 million people? |
| cord-322078-cli7mpev | How should we expect the public to understand such a situation and to behave accordingly, if we do n't know ourselves what's going on based on facts? |
| cord-316050-mqrx003q | A spatial econometric approach to model spillover effects in tourism flows Do political instability, terrorism, and corruption have deterring effects on tourism development even in the presence of Unesco heritage? |
| cord-316050-mqrx003q | The German source market perceptions: How risky is Turkey to travel to? |
| cord-316050-mqrx003q | could it get worse? |
| cord-320773-zisujjsx | Declarations of interest: none Estimating the number of infections and the impact of non- pharmaceutical interventions on COVID-19 in 11 European Do low- trust societies do better in a pandemic? |
| cord-320773-zisujjsx | Protecting privacy and data while using apps and biometrics How will governments know when to lift restrictions? |
| cord-268082-znfo9xgv | Another, hypothetical, way to think about the results is the following: if all planned additional expenditures were theoretically spent in 2020( in a non- COVID-19 economy), by how much would GDP increase in 2020? |
| cord-268082-znfo9xgv | First, what is the increase in GDP per country due to the plan? |
| cord-268082-znfo9xgv | How Much Could an Expansion in the North Help the South? |
| cord-268082-znfo9xgv | How do these results compare with those of other models, in particular DSGE models? |
| cord-268082-znfo9xgv | Second, how do economic structures of member states allow them to take part in the positive effects of the plan through spillover effects from others? |
| cord-268082-znfo9xgv | r e l a n d The EU's recovery fund proposals: crisis relief with massive redistribution Having the cake, but slicing it differently: how is the grand EU recovery fund allocated? |
| cord-020941-1qwbkg9o | A bait delivered immunocontracpetive vaccine for the European fox( Vulpes vulpes) by the year 2002? |
| cord-020941-1qwbkg9o | And no birds sing: the story of ecological disaster in a tropical paradise Rabbit and fox introductions in Tierra del Fuego: History and assessment of the attempts at biological control of the rabbit infestation Parasitoids as limiting and selective factors: Can biological control be evolutionary stable? |
| cord-020941-1qwbkg9o | Can predators regulate small mammal populations? |
| cord-020941-1qwbkg9o | Capillaria hepatica regulate abundance in wild house mice? |
| cord-020941-1qwbkg9o | Panacea or Pandora's box? |
| cord-020941-1qwbkg9o | Predation models for primary and secondary prey species Can foxes be controlled by reducing their fertility? |
| cord-354738-4rxradwz | A framework for analysis Here a virus, there a virus, everywhere the same virus? |
| cord-354738-4rxradwz | And is the zoonotic risk posed by bats decreased accordingly? |
| cord-354738-4rxradwz | Are fewer viruses prevalent in European bats because of the lower abundance of species in the more temperate Europe? |
| cord-354738-4rxradwz | In Food Security in a Global Economy Veterinary Medicine and Public Health Bats and viruses: A brief review Mass extinctions, biodiversity and mitochondrial function: Are bats-special‖ as reservoirs for emerging viruses? |
| cord-354738-4rxradwz | Microbial biogeography? |
| cord-330180-lvn4hqk5 | European policymaking on the tobacco advertising ban: the importance of escape routes Patient's rights: a lost cause or missed opportunity? |
| cord-330180-lvn4hqk5 | Is health recognized in the EU's policy process? |
| cord-330180-lvn4hqk5 | Recent achievements CAP on Health? |
| cord-330180-lvn4hqk5 | The European centre for disease prevention and control: hub or hollow core? |
| cord-330180-lvn4hqk5 | What if DG Internal Market was turned into our greatest weapon?" |
| cord-330180-lvn4hqk5 | What is in there for you? |
| cord-029402-5gun91ep | 5b_previ ew.shtml? |
| cord-029402-5gun91ep | And are they economically and politically feasible? |
| cord-029402-5gun91ep | The Guardian Why has eastern Europe suffered less from coronavirus than the west? |
| cord-029402-5gun91ep | The central European manufacturin core: What is driving regional production sharing? |
| cord-029402-5gun91ep | What policies and what reforms should be implemented to pursue this objective? |
| cord-029402-5gun91ep | cord-029402- 5gun91ep authors: Celi, Giuseppe; Guarascio, Dario; Simonazzi, Annamaria title: A fragile and divided European Union meets Covid-19: further disintegration or ‘ Hamiltonian moment ’? |
| cord-271765-altqn10l | Accessible for All? |
| cord-271765-altqn10l | Can information about pandemics increase negative attitudes toward foreign groups? |
| cord-271765-altqn10l | ESMH selection: Sources of information about Coronavirus Twitter, and misinformation: A dangerous combination? |
| cord-271765-altqn10l | For? |
| cord-271765-altqn10l | How young Chinese depend on the media during public health crises? |
| cord-271765-altqn10l | Qué es la Accesibilidad Web? |
| cord-271765-altqn10l | RQ1: Does the WHO make itself accessible to all groups of citizens according to accepted standards in the field of the Internet? |
| cord-271765-altqn10l | What Is COVID-19? |
| cord-271765-altqn10l | What aspects of web content analysis can be improved, and which audiences are affected? |
| cord-301856-71syce4n | A causal mechanism for childhood acute lymphoblastic leukaemia Association between Helicobacter pylori infection and multiple sclerosis: a systematic review and meta- analysis Is Toxoplasma gondii infection protective against multiple sclerosis risk? |
| cord-301856-71syce4n | Are other newly described genetic regulatory pathways, such as interfering RNA or long noncoding RNAs, also influenced by pathogen- driven evolutionary processes in different populations globally? |
| cord-301856-71syce4n | Are the mechanisms of resistance to infection transmitted only via genetic modifications, or can epigenetic adaptations to resistance also be transmitted to the progeny, and under what circumstances? |
| cord-301856-71syce4n | Are there specific immune processes that are preferentially impacted by evolutionary pressures? |
| cord-301856-71syce4n | Can some of the reasons for these changes lie among some of those bacteria that we have somehow lost in our microbiome? |
| cord-301856-71syce4n | Does caspase-12 suppress inflammasome activation? |
| cord-301856-71syce4n | How does genetic variation of the expression of a specific variant vary between different cell subsets and how does it affect the overall phenotype of an individual within a population? |
| cord-301856-71syce4n | How long does the genome of a given population take to adapt to a new infectious threat? |
| cord-301856-71syce4n | Since many of the variants causing autoimmune diseases are linked to an enhanced responsiveness to pathogens that is no longer needed in developed countries, could these genes and their related pathways be employed as targets for new putative therapeutic approaches against inflammatory/ autoimmune syndromes? |
| cord-301856-71syce4n | We thank Laszlo A. Groh for Which are the strongest evolutionary forces that drive the evolution of the human innate immune system? |
| cord-271687-sxl8g85p | ( Panthera leo) Movement of badgers( Meles meles) in a high- density population: Individual, population and disease effects Contaminant- induced immunotoxicity in harbour seals: Wildlife at risk? |
| cord-271687-sxl8g85p | Is transfer of zoonoses from bats to terrestrial vertebrates generally rare due to a lack of appropriate contact? |
| cord-271687-sxl8g85p | Might the answer lie in changes in land use? |
| cord-271687-sxl8g85p | Or is there regular inter- specific transmission of other viruses but these go undetected because they lack the extreme pathogenicity of Hendra and Nipah viruses to stimulate screening efforts? |
| cord-271687-sxl8g85p | So why have badger populations risen? |
| cord-271687-sxl8g85p | structuring and species specificity of a pathogen in wildlife hosts? |
| cord-023993-rncleqqy | And how are these people's traffickers?" |
| cord-023993-rncleqqy | But where? |
| cord-023993-rncleqqy | How could be accomplished the aims to become a historic leap in the consolidation of a European area of freedom of movement without internal borders? |
| cord-023993-rncleqqy | Is this what the Church wants? |
| cord-023993-rncleqqy | Migraciones sin respuestas Alemania busca extranjeros para 1, 2 millones de empleos, El País, 20 dic How to stop migration towards big cities? |
| cord-023993-rncleqqy | No 604/2013 of the European Parliament and of the Council of 26 Maritime dimension in the fight against illegal migration on the Western Mediterranean route Sbarchi? |
| cord-023993-rncleqqy | Once accepted as our guests, what to do with them? |
| cord-023993-rncleqqy | What alternative do citizens of many African countries have to come to Europe? |
| cord-023993-rncleqqy | What should be a reasonable attitude to avoid an uncontrolled moving of illegal migrants within the Schengen area? |
| cord-023993-rncleqqy | What should be the European criteria for who is welcome to Europe and who is not, to avoid an uncontrolled migration into our continent? |
| cord-026037-0gg9fm7x | 19 Cosmopolitan ideals and national sentiment Is EU supranational governance a challenge to liberal constitutionalism? |
| cord-026037-0gg9fm7x | Are we on the right track when deciding on a governance for the current EU agenda? |
| cord-026037-0gg9fm7x | How should we combine a republican type of institutional representation with a so- called liberal form, one based on the maximization of State interests? |
| cord-026037-0gg9fm7x | How should we frame legitimate relations of mutual cooperation in a multilevel regional polity? |
| cord-026037-0gg9fm7x | How should we reconcile the peculiarity of the European constituent power with the idea of its open- ended finality? |
| cord-026037-0gg9fm7x | How should we think of the interconnections between different European demoi? |
| cord-026037-0gg9fm7x | Is this a sufficient impediment for resorting to radical alternatives? |
| cord-026037-0gg9fm7x | More generally, has the EU governance and its integration process diminished its original liberal constitutional project and contributed, inadvertently, to the rise of the present crisis in all of its most significant dimension? |
| cord-026037-0gg9fm7x | Where will the EU position itself? |
| cord-026037-0gg9fm7x | Which European Union? |
| cord-026037-0gg9fm7x | Will these measures be enough to push back the upcoming crisis? |
| cord-022910-kjs6je2u | ( i.e. can respiratory sensitization occur via other exposures?) are discussed. |
| cord-022910-kjs6je2u | ( within the company or with your customers or endusers) related to some of the enzymes or cultures that your company handles? |
| cord-022910-kjs6je2u | An industrial hygiene perspective Exposure to multiple indoor allergens in US homes and its relationship to asthma IgE- Mediated Asthma and Rhinitis I: A Role of Allergen Exposure? |
| cord-022910-kjs6je2u | Are you able to rank the allergy risk between individual processes or products? |
| cord-022910-kjs6je2u | Are your company using any methods for predicting a possible risk of sensitization for any particular product? |
| cord-022910-kjs6je2u | Can you pinpoint any products, processes or unit operations that are related to either particularly high risk for sensitization or particularly low risk for sensitization? |
| cord-022910-kjs6je2u | Defining occupational and consumer exposure limits for enzyme protein respiratory allergens under REACH Are we closer to developing threshold limit values for allergens in the workplace? |
| cord-022910-kjs6je2u | Has your work with enzymes or cultures given you an impression on the doseresponse- relationsships in allergy development? |
| cord-022910-kjs6je2u | Have your company developed any special formulations that reduce the risk of exposure to cultures or enzymes? |
| cord-022910-kjs6je2u | Occupational part: • Is your company monitoring allergies among workers and/or customers? |
| cord-022910-kjs6je2u | To which extent are microorganisms, microbial products and enzymes respiratory sensitizers? |
| cord-022910-kjs6je2u | Two cases of occupational rhinitis caused by biodiastase in hospital and pharmaceutical workers Is fungal alpha- amylase in bread an allergen? |
| cord-022910-kjs6je2u | When did your company start to handle those enzymes or cultures? |
| cord-022910-kjs6je2u | Which categories of enzyme and/or microbial cultures does your company produce and/or use? |
| cord-022910-kjs6je2u | • How many workers are exposed to each of those categories? |
| cord-353775-ogb56xg9 | A new realtime economic tracker based on private sector data Supply and demand shocks in the COVID-19 pandemic: An industry and occupation perspective How many jobs can be done at home? |
| cord-353775-ogb56xg9 | Are they evenly distributed? |
| cord-353775-ogb56xg9 | Following these authors, we use fifteen questions from the Occupational Information Network( O*NET) database such as,'is the work done outdoors?' |
| cord-353775-ogb56xg9 | How did COVID-19 stabilization policies affect spending and employment? |
| cord-353775-ogb56xg9 | How large are the wage losses experienced by workers during the lockdown? |
| cord-353775-ogb56xg9 | Our findings show an increase in inequality for all European countries but, would inequality changes be different enough to increase inequality between countries? |
| cord-353775-ogb56xg9 | Poverty equivalent growth rate Which workers bear the burden of social distancing policies? |
| cord-353775-ogb56xg9 | What is the share of occupations that allow teleworking in Europe? |
| cord-353775-ogb56xg9 | Will Covid-19 affect inequality? |
| cord-353775-ogb56xg9 | or,'does it require significant physical activity?' |
| cord-319365-v75pvlka | A Study Based on the 4th European Survey of Working Conditions Is Europe ready for flexicurity? |
| cord-319365-v75pvlka | A tale of Pi( i) gs and farmers A'civic turn'in Scandinavian family migration policies? |
| cord-319365-v75pvlka | An overview of some recommended measures of effect size Creativity and turnover intention among hotel chefs: the mediating effects of job satisfaction and job stress How far do cultural differences explain the differences between nations? |
| cord-319365-v75pvlka | Beyond strategic human resource management: is sustainable human resource management the next approach? |
| cord-319365-v75pvlka | From these objectives, the following research question is derived: Does the clustering of European countries according to institutional characteristics correctly reflect the differences in labor conditions and subsequently job satisfaction across Europe? |
| cord-319365-v75pvlka | Much Ado about Social Outcomes? |
| cord-319365-v75pvlka | Routledge Convergence or divergence of contingent employment practices? |
| cord-319365-v75pvlka | The effect of job satisfaction on employee commitment Review of 30 years of longitudinal studies on the association between job insecurity and health and well- being: is there causal evidence? |
| cord-319365-v75pvlka | The impact of talent management on job satisfaction and employee performance in public sector banks of Rajasthan Supporting the academic majority: policies and practices related to part- time faculty's job satisfaction Do better workplace environmental conditions improve job satisfaction? |
| cord-319365-v75pvlka | The question is:"In general, are you very satisfied, satisfied, not very satisfied or not at all satisfied with your working conditions?". |
| cord-319365-v75pvlka | What are the reasons for differences in job satisfaction across Europe? |
| cord-319365-v75pvlka | Work motivation and job satisfaction in the Nordic countries European Foundation for the Improvement of Living and Working Conditions Unemployment and Activity by Sex Fiscal unions Is there a Latin model in the management of human resources? |
| cord-319365-v75pvlka | evidence from the cut flower industry in Ethiopia Is Work in Europe Decent? |
| cord-034205-53i2tw65 | : what does it take to be a superstar? |
| cord-034205-53i2tw65 | A note on forecasting emerging market exchange rates: evidence on anti- herding Information precision in online communities: player valuations on www.transfermarkt.de Status quo of media rights in European football: can we do better than no- single- buyer rule? |
| cord-034205-53i2tw65 | A winner's curse in the bidding process for broadcasting rights in football? |
| cord-034205-53i2tw65 | Agree or disagree? |
| cord-034205-53i2tw65 | Clear vision with transfer windows Fananleihen als Finanzierungsmöglichkeit von Sportclubs? |
| cord-034205-53i2tw65 | Eike title: The sky is the limit?! |
| cord-034205-53i2tw65 | Eine Bestandsaufnahme am Beispiel der Fußballbundesliga Moneyball revisited: effort and team performance in professional soccer No pain, no gain? |
| cord-034205-53i2tw65 | Has the Premier League transfer bubble burst? |
| cord-034205-53i2tw65 | On the role of negotiations for the valuation of business enterprises Team salaries and playing success in sports: a comparative perspective Die ökonomischen Institutionen der Teamsportindustrie Private firm, public corporation or member's association- governance structures in European football Zombierennen und Patenonkel- Warum deutsche Fussballklubs in der Champions League den Kürzeren ziehen Financial fair play in European Club Football- what is it all about? |
| cord-034205-53i2tw65 | The New York Times Evidence of fueling of the 2000 new economy bubble by foreign capital inflow: implications for the future of the US economy and its stock market Football league transfers: a comparison of negotiated fees with arbitration settlements Herding in financial markets: a review of the literature Soft budget constraints in professional football Entry into exit: insolvency in English Professional Football Insolvencies in professional football: a German Sonderweg? |
| cord-034205-53i2tw65 | The show must go on"!? |
| cord-034205-53i2tw65 | The winner's curse: why is the cost of sports mega- events so often underestimated? |
| cord-034205-53i2tw65 | Who owns England's game? |
| cord-034205-53i2tw65 | the labour market in association football: who gets transferred and for how much? |
| cord-016140-gvezk8vp | ( What is"state security","terrorism","a serious crime"?). |
| cord-016140-gvezk8vp | And even if workable( e.g., thanks to the help of the digital assistants), are they enough? |
| cord-016140-gvezk8vp | Can the limitations of non- discrimination law be justified if they are regarded as not fair, as in the example of insurance companies raising premiums after processing health data? |
| cord-016140-gvezk8vp | Does he have the right to be present when such data are examined? |
| cord-016140-gvezk8vp | Does the inviolability of the home extend to the data that are stored on a distant server? |
| cord-016140-gvezk8vp | Here is a challenge: how to technologically implement negotiability of contracts and the framework of binding law in electronic, machine- readable form? |
| cord-016140-gvezk8vp | How easy will it be to establish causation in a case where the system itself generates the information and undertakes the actions? |
| cord-016140-gvezk8vp | How will the individual deal with such problems? |
| cord-016140-gvezk8vp | If it is difficult to distinguish between hardware and software from a technological perspective, why should we draw such a distinction from a legal perspective? |
| cord-016140-gvezk8vp | Instead of focusing on reducing the amount of data collected alone, should we admit that they are indispensable for the operation of AmI, and focus rather on empowering the user with a means to control such processing of personal data? |
| cord-016140-gvezk8vp | Is the individual informed when such data are accessed? |
| cord-016140-gvezk8vp | Is the legal system flexible enough to endorse this? |
| cord-016140-gvezk8vp | It shows that there is a choice: should the law change because of the"code"? |
| cord-016140-gvezk8vp | Privacy's Death or Saviour? |
| cord-016140-gvezk8vp | Should the distinction between the two regimes remain? |
| cord-016140-gvezk8vp | Should this, however, lead to diminishing the right to privacy? |
| cord-016140-gvezk8vp | Should we not try to look for an approach granting the individual even more control? |
| cord-016140-gvezk8vp | Thus arises the fundamental question: Do we want to minimise personal data collection? |
| cord-016140-gvezk8vp | What are the conditions for accessing such data? |
| cord-016140-gvezk8vp | What is the sense of protecting data in one country if they are transferred to a country not affording comparable( or any) safeguards? |
| cord-016140-gvezk8vp | Who is then to blame? |
| cord-016140-gvezk8vp | the law change"code"and thus ensure that certain values are protected? |
| cord-030909-6if3qquj | ( European Climate Law Will COVID-19 fiscal recovery packages accelerate or retard progress on climate change? |
| cord-030909-6if3qquj | BBC Global Energy and CO2 Emissions in 2020 Does telework weaken urban structure- travel relationships? |
| cord-030909-6if3qquj | COVID-19 fiscal recovery packages accelerate or retard progress on climate change? |
| cord-030909-6if3qquj | Can environmental regulation enhance innovation and competitiveness? |
| cord-030909-6if3qquj | Can negative supply shocks cause demand shortages? |
| cord-030909-6if3qquj | Conforming or Transforming the Dominant Agro- Food Regime? |
| cord-030909-6if3qquj | Do the impacts differ among environmental pressures? |
| cord-030909-6if3qquj | Do these effects go beyond European countries through global supply chains? |
| cord-030909-6if3qquj | Does the Fossil Fuel Divestment Movement Impact New Oil& Gas Fundraising? |
| cord-030909-6if3qquj | Even if one accepts that fossil fuel companies were eligible for PEPP, then our preliminary evidence still raises the significant question, why the ECB was more likely to directly finance those fossil fuel firms that are likely more harmful to the planet( i.e. have a higher GHG intensity)? |
| cord-030909-6if3qquj | Furthermore, if developed countries implement recovery plans that include provisions to reduce emissions in significant ways, as has been discussed in the European Union, will Latin American countries be able to respond in the same way? |
| cord-030909-6if3qquj | How can long- term economic dislocation be avoided? |
| cord-030909-6if3qquj | How could the ECB's monetary policy support the sustainable finance transition? |
| cord-030909-6if3qquj | How does this picture fit with the European response to COVID-19 in the context of the EGD? |
| cord-030909-6if3qquj | How elastic are environmental responses to demand drops? |
| cord-030909-6if3qquj | Is environmental regulation bad for competition? |
| cord-030909-6if3qquj | On the basis of these short- term responses, what is the relationship between economic growth and environmental pressure? |
| cord-030909-6if3qquj | Renewable energy subsidies: Secondbest policy or fatal aberration for mitigation? |
| cord-030909-6if3qquj | Should that happen, will the economic cost burdens be outweighed by the realized environmental gains? |
| cord-030909-6if3qquj | Technology- Specific Deployment Policies Be Cost- Effective? |
| cord-030909-6if3qquj | The Coronavirus Stimulus Package: How large is the transfer multiplier? |
| cord-030909-6if3qquj | The Global Commission on Adaptation Does social distancing matter? |
| cord-030909-6if3qquj | The influence of energy efficiency on other natural resources use: An input- output perspective Rebound effects and ICT: a review of the literature Energy efficiency and consumptionthe rebound effect- a survey Is telework effective for organizations? |
| cord-030909-6if3qquj | The publicly available datasets on confirmed COVID-19 54 cases and deaths provide a key opportunity to better understand the drivers of the pandemic Will spring slow spread of coronavirus in northern hemisphere? |
| cord-030909-6if3qquj | This integrated analysis could answer urgent research questions: What are the short- term impacts on emissions and resource consumption of the current and predicted declines in final demand? |
| cord-030909-6if3qquj | Will COVID-19 fiscal recovery packages accelerate or retard progress on climate change? |
| cord-030909-6if3qquj | Will Covid-19 have a lasting impact on the environment? |
| cord-030909-6if3qquj | Will the economy, too? |
| cord-030909-6if3qquj | mimeo Financial data science: the birth of a new financial research paradigm complementing econometrics? |
| cord-004894-75w35fkd | 0.56; 95%CI 0.43- 0.69), the surveillance database slightly(?= 0.14; 95%CI 0.02- 0.27). |
| cord-004894-75w35fkd | 51% had cholinesterase levels below the mean value of 0.7? |
| cord-004894-75w35fkd | Are they different from the''classic''tools and frameworks of clinical epidemiology? |
| cord-004894-75w35fkd | Conclusion: Long- term ICS use(> 2 years) seems to be associated with a reduced? |
| cord-004894-75w35fkd | Do these questions about needs give other results compared to questions about prevalence of health problems? |
| cord-004894-75w35fkd | Do we feel comfortable with this''black- box''reasoning, i.e. do we question the role of pathophysiological and mechanistic reasoning in clinical medicine? |
| cord-004894-75w35fkd | FEV1, with respect to non- users, of 10.4(95%CI: 1.6- 19.2) mL/ year.? |
| cord-004894-75w35fkd | For reliability, Cohen's kappa coefficient(?) was applied. |
| cord-004894-75w35fkd | Have GPs treatment arm preferences? |
| cord-004894-75w35fkd | How can epidemiologic data be used for( quantitative) risk assessment? |
| cord-004894-75w35fkd | How much sense does it make for epidemiology to play with and scrutinize proteomics and genomics approaches in epidemiology and clinical medicine? |
| cord-004894-75w35fkd | Infection diseases: Beneficial or Disaster for man? |
| cord-004894-75w35fkd | Is population- based primary prevention more favourable than secondary prevention( risk factor reduction in coronary heart disease( CHD) patients)? |
| cord-004894-75w35fkd | Methods: From the Netherlands Cancer Registry patients were selected with invasive pT1(? 2.0 cm) or pT2( 2.1- 5.0 cm) tumours, without metastasis at time of diagnosis. |
| cord-004894-75w35fkd | Methods: We retrospectively analysed medical data from 3,166 episodes of LRTI among patients? |
| cord-004894-75w35fkd | Objective: What factors are associated with referral to physiotherapy or specialist in non- traumatic armneck- shoulder complaints in general practice, during the first consultation? |
| cord-004894-75w35fkd | Objectives: Our question was: Can we understand RCT outcomes better with qualitative research? |
| cord-004894-75w35fkd | Objectives: The question is: Are observed increasing rates due to actual changes in incidence rates or mainly caused by changes in registration practice or artefacts? |
| cord-004894-75w35fkd | Our question is: Does BPSA yield improved interval estimation of treatment effects compared to PSA? |
| cord-004894-75w35fkd | Results: When adjusting for all covariates, ICS use for> 2 years significantly reduced? |
| cord-004894-75w35fkd | Should a researcher foresee press reaction and what can be done to prevent negative consequences? |
| cord-004894-75w35fkd | THE FUTURE: DO THEY FULFIL IT? |
| cord-004894-75w35fkd | The ODP database was moderately reliable(? |
| cord-004894-75w35fkd | The annual FEV1 decrease(? FEV1) was analysed by multi- level regression models, according to age, sex, height, BMI, occupation, familiarity of asthma, hospitalization for asthma( baseline factors); cumulative time of inhaled corticosteroid( ICS) use and annual weight gain during the follow- up; lifetime pack- years smoked. |
| cord-004894-75w35fkd | The use of BCS and BCS- RT in pT1(? 2 cm) and pT2-tumours( 2- 5 cm) was investigated in the Netherlands in the period 1990 and 2001. |
| cord-004894-75w35fkd | Two different IFN- g tests will be done in those with a TST induration of? |
| cord-004894-75w35fkd | Viruses were detected in 58% of the cases,? |
| cord-004894-75w35fkd | What are at meaningful and consequential examples of current findings in proteomics, genomics and similar approaches in biomedical research? |
| cord-004894-75w35fkd | What is the effect on allocation concealment and selection bias? |
| cord-004894-75w35fkd | Which factors are associated with differences in utilisation of GP care? |
| cord-004894-75w35fkd | Which factors are associated with ethnic differences in self- rated health? |
| cord-004894-75w35fkd | Whose responsibility is this misunderstanding between press and researchers? |
| cord-004894-75w35fkd | the main biological, clinical and public health implications of current findings in these research fields? |
| cord-001221-due9tloa | 1) Is this a true occlusion( how to differentiate it from adynamic ileus)? |
| cord-001221-due9tloa | 2) Does the obstruction concern the small bowel or the colon( impacting on the decision to operate or not)? |
| cord-001221-due9tloa | 4) Are there signs of bowel ischaemia? |
| cord-001221-due9tloa | A-017 17:00 C. MR/ PET: do we really need it? |
| cord-001221-due9tloa | And if so, which kinds of images( CT, MRI, x- ray, etc).? |
| cord-001221-due9tloa | Are there associated findings other than GGO, such as nodules, reticulation or focal disease, and distribution of findings that can narrow the differential diagnosis? |
| cord-001221-due9tloa | Are there specific radiological and HRCT findings that can help us differentiate GGO in autoimmune inflammatory conditions from infectious and neoplastic processes? |
| cord-001221-due9tloa | Are there sufficient data to support the implementation of individual lung cancer screening in clinical practice? |
| cord-001221-due9tloa | Cardiac MR/ PET: Do we really need it? |
| cord-001221-due9tloa | How accurate and prognostically valid is coronary CT angiography? |
| cord-001221-due9tloa | How can we manage the portability of patients'data( security issues, data loss, etc).? |
| cord-001221-due9tloa | How can we reduce the amount of contrast agent by volume? |
| cord-001221-due9tloa | How can we reduce the amount of iodine concentration in the contrast agent? |
| cord-001221-due9tloa | How can we reduce the time of cardiac CT studies? |
| cord-001221-due9tloa | How can we reduce the x- ray dose? |
| cord-001221-due9tloa | How should subjects be informed about screening? |
| cord-001221-due9tloa | In view of this rapid technological development, again radiology falls in the middle of a storm and is asked to find a solution to problem: are tablets suitable to read and report DICOM images? |
| cord-001221-due9tloa | Is cell imaging relevant for the clinic? |
| cord-001221-due9tloa | Key components of differential diagnosis is configuration of the enhancement( does it follow the orientation of the milk duct or not?) |
| cord-001221-due9tloa | Right heart and chronic respiratory diseases: can CT be used as a onestop- shop? |
| cord-001221-due9tloa | Stereotactic radiofrequency ablation of liver tumours: does improved targeting increase tumour response? |
| cord-001221-due9tloa | Therefore, what happens in those patients in whom we found highly suggestive lesions but have never had symptoms? |
| cord-001221-due9tloa | What about the alternatives of waiting for additional data from ongoing trials or the validation of new biomarkers of lung cancer, permitting better selection of screened population before implementing individual lung cancer screening? |
| cord-001221-due9tloa | What are the most optimised risk profiles for screening? |
| cord-001221-due9tloa | What are the optimal follow- up duration and screening interval? |
| cord-001221-due9tloa | What are the protocols with the lowest radiation dose in clinical practice? J.-F. |
| cord-001221-due9tloa | What are the technical and positive screen management requirements? |
| cord-001221-due9tloa | What is the cause of the obstruction? |
| cord-001221-due9tloa | What is the minimum level of infrastructure support and organisation required? |
| cord-001221-due9tloa | What is the radiographer's role in cardiac CT studies? |
| cord-001221-due9tloa | What will be the impact on teleradiology? |
| cord-001221-due9tloa | Where are the turf battles in diagnostic imaging? |
| cord-001221-due9tloa | Why is it important in your imaging protocol of the IAC and CPA region to use gadolinium? |
| cord-001221-due9tloa | how? |
| cord-022889-lv6fy6e6 | -Are plant ncRNAs more stable than animal( mammalian) ncRNAs? |
| cord-022889-lv6fy6e6 | -Do changes in RNAse activity, due to pathologies or human polymorphisms, influence dietary exposure? |
| cord-022889-lv6fy6e6 | -Do exogenous ncRNAs( naked RNAs) resist the conditions of the gastrointestinal tract environment? |
| cord-022889-lv6fy6e6 | -How does exogenous RNAs uptake in mammalian cells occur? |
| cord-022889-lv6fy6e6 | -What are the biological barriers for the exogenous RNAs after absorption and entering into the mammalian circulatory system? |
| cord-022889-lv6fy6e6 | -What are the biological barriers to consumed RNAs? |
| cord-022889-lv6fy6e6 | -What are the main differences between mammalian and plant ncRNAs? |
| cord-022889-lv6fy6e6 | -What are the specific tissue barriers to exogenous ncRNA function? |
| cord-022889-lv6fy6e6 | -What is known about the half- life of ncRNAs? |
| cord-022889-lv6fy6e6 | -What is known about the movement of plant ncRNAs? |
| cord-022889-lv6fy6e6 | -What is the cellular fate of exogenous ncRNAs once inside the cell? |
| cord-022889-lv6fy6e6 | -What is the function of plant ncRNAs? |
| cord-022889-lv6fy6e6 | -What routes of administration have been used for RNA- based therapeutics? |
| cord-022889-lv6fy6e6 | -What type of ncRNAs are described in plants? |
| cord-022889-lv6fy6e6 | -Which human or animal cells( i.e. lymphocytes, macrophages, myeloid) are possibly involved in immune responses mediated by plant- derived ncRNAs? |
| cord-022889-lv6fy6e6 | -Which innate immunity mediators( i.e. chemokines, cytokines) have been identified in humans and animals as associated to effects of plant- derived ncRNAs? |
| cord-022889-lv6fy6e6 | -Why is it relevant to consider ncRNA stability outside the organism of origin( plant)? |
| cord-022889-lv6fy6e6 | Because this specific topic is especially salient to future understanding of the possible food/ feed risk assessment of ncRNAs- based GM plants, all the identified studies were further evaluated by title and abstract and their relevance to answering the identified key questions: does the literature describe the effect of exogenous plant- origin ncRNAs when consumed orally? |
| cord-022889-lv6fy6e6 | In silico identification of plant miRNAs in mammalian breast milk exosomes-- a small step forward? |
| cord-022889-lv6fy6e6 | In silico identification of plant miRNAs in mammalian breast milk exosomes-- a small step forward? |
| cord-022889-lv6fy6e6 | Only one key question was identified in the preparatory phase:-What are the biological barriers within the gastrointestinal tract to ingested exogenous RNAs? |
| cord-022889-lv6fy6e6 | Plant miRNAs found in human circulating system provide evidences of cross kingdom RNAi Detection of Plant miRNAs Abundance in Human Breast Milk In silico identification of plant miRNAs in mammalian breast milk exosomes-- a small step forward? |
| cord-022889-lv6fy6e6 | Selected full- text studies were analysed for their relevance to answering the following key question:-Is there evidence for influence of exogenous plant ncRNAs on the gut microbiota related to the immune system? |
| cord-022889-lv6fy6e6 | Since these findings are important for the risk assessment of ncRNA- based GM plants, the key question was presented in its positive and negative forms as follow: are there studies describing the presence of exogenous RNAs in the biological fluids and tissues of humans and/or animals? |
| cord-022889-lv6fy6e6 | Studies were further evaluated for their relevance to answer the key questions identified for this section:-What are the pharmacokinetic properties of RNA- based therapeutics? |
| cord-022889-lv6fy6e6 | The complex exogenous RNA spectra in human plasma: an interface with human gut biota? |
| cord-022889-lv6fy6e6 | The complex exogenous RNA spectra in human plasma: an interface with human gut biota? |
| cord-022889-lv6fy6e6 | The key questions identified to refine the literature search for this specific topic were:-Is there evidence of any toxicological effects of plant- derived dietary exogenous ncRNAs? |
| cord-022889-lv6fy6e6 | The key questions identified using the above key words were:-Which test methods or approaches are available to investigate the possible role of plant- derived exogenous ncRNAs on the immune system of humans or animals? |
| cord-022889-lv6fy6e6 | The search was refined by filtering for relevance to answering the identified key questions: is there any clear transport of exogenous ncRNAs into mammalian cells? |
| cord-022889-lv6fy6e6 | To assist and refine the search, studies were further filtered for their relevance to the key question identified: is the oral route of administration relevant for RNA- based therapeutic development? |
| cord-022889-lv6fy6e6 | To more appropriately cover this section and to refine the search, the following key questions were identified during the preparatory phase:-What is the general amount of RNAs naturally occurring in edible plants? |
| cord-022889-lv6fy6e6 | any natural vehicles for oral administration of exogenous ncRNAs? |
| cord-022889-lv6fy6e6 | bee pollen miRNAs in serum of mice Chemical modification patterns compatible with high potency dicer- substrate small interfering RNAs Is RNA interference involved in intrinsic antiviral immunity in mammals? |
| cord-022889-lv6fy6e6 | certain types of plant ncRNAs more or less stable than others? |
| cord-022889-lv6fy6e6 | derived extracellular vesicles attenuates arthritis in two mouse models Exosomes as a Nanodelivery System: a Key to the Future of Neuromedicine? |
| cord-022889-lv6fy6e6 | disease conditions modify the pharmacokinetic properties of RNAs when administered to mammals? |
| cord-022889-lv6fy6e6 | exogenous ncRNAs also used to exert RNAi effects in fish or birds? |
| cord-022889-lv6fy6e6 | exogenous ncRNAs consumed in an amount sufficient to exert a local biological effect?Are there other common examples of exogenous ncRNAs( other than plant- origin) that could exert a biological effect on the GI tract and its annex glands when ingested orally? |
| cord-022889-lv6fy6e6 | exogenous ncRNAs evaluated quantitatively? |
| cord-022889-lv6fy6e6 | exposure to RNAs change in different diet types? |
| cord-022889-lv6fy6e6 | human or animal immune response(s), innate or adaptive, are possibly associated with administration of plant- derived exogenous ncRNAs? |
| cord-022889-lv6fy6e6 | is it known about the pharmacodynamic properties of RNA- based therapeutics? |
| cord-022889-lv6fy6e6 | key questions were identified and the studies then further filtered for their relevance to the these:-Are exogenous RNAs taken up by mammalian cells? |
| cord-022889-lv6fy6e6 | molecular mechanisms are involved in exogenous ncRNAs trafficking inside the cell? |
| cord-022889-lv6fy6e6 | ncRNAs- based therapeutics-delivered by oral administration or other GI tract routes of administration- exert a biological effect in the GI tract or its annex glands? |
| cord-022889-lv6fy6e6 | orthologous of environmental RNAs transporters in lower organisms( i.e. SID family of proteins) involved in the mammalian exogenous ncRNA mechanism of uptake? |
| cord-022889-lv6fy6e6 | percentage of total plant RNAs are ncRNAs, miRNAs, siRNAs, lncRNAs or dsRNAs? |
| cord-022889-lv6fy6e6 | possible interactions related to unintended RNAi- mediated gene regulation? |
| cord-022889-lv6fy6e6 | possibly mediated by administration of plant- derived ncRNAs? |
| cord-022889-lv6fy6e6 | so, what makes a plant ncRNA more stable than its animal( mammalian) counterpart? |
| cord-022889-lv6fy6e6 | stability properties under GI tract conditions normally evaluated? |
| cord-022889-lv6fy6e6 | the literature describe negative results or contradictory results regarding the possible biological effect of ncRNAs when consumed orally? |
| cord-022889-lv6fy6e6 | the toxicological effects related to RNAi- mediated interaction with the human or animal genome? |
| cord-022889-lv6fy6e6 | there studies contradicting the presence of exogenous RNAs in the biological fluids and tissues of humans and/or animals? |
| cord-022889-lv6fy6e6 | types of formulation( delivery vehicles) are tested for RNA- based therapeutics for the oral route of administration or other gastrointestinal tract routes of administration? |